Treace Medical Concepts, Inc.TMCINASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-48.76M
↓ 68% below average
Average (5y)
$-29.10M
Historical baseline
Range
High:$-5.56M
Low:$-48.76M
CAGR
+40.6%
Consistent expansion
PeriodValueChange
2024$-48.76M-5.9%
2023$-46.03M-1.2%
2022$-45.49M-128.6%
2021$-19.90M-257.7%
2020$-5.56M+37.4%
2019$-8.88M-